G Hess

2.4k total citations
30 papers, 402 citations indexed

About

G Hess is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, G Hess has authored 30 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 18 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in G Hess's work include Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (11 papers) and Hepatitis Viruses Studies and Epidemiology (8 papers). G Hess is often cited by papers focused on Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (11 papers) and Hepatitis Viruses Studies and Epidemiology (8 papers). G Hess collaborates with scholars based in Germany, United States and Greece. G Hess's co-authors include Michael P. Manns, Spyridon P. Dourakis, Andrea Horsch, S. Hadziyannis, Melanie Deutsch, K-H Meyer zum Büschenfelde, E.K. Manesis, W. Arnold, K. H. Meyer zum Büschenfelde and K.‐H. Meyer zum Büschenfelde and has published in prestigious journals such as The Journal of Immunology, Hepatology and Gut.

In The Last Decade

G Hess

28 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Hess Germany 10 270 263 50 46 41 30 402
Francesca Dal Pero Italy 12 347 1.3× 390 1.5× 107 2.1× 27 0.6× 22 0.5× 19 504
Juliane Halangk Germany 11 312 1.2× 346 1.3× 29 0.6× 42 0.9× 31 0.8× 20 530
Karl‐Herrmann Meyer zum Büschenfelde Germany 10 273 1.0× 303 1.2× 112 2.2× 26 0.6× 41 1.0× 11 468
Giuseppe Portera Italy 10 448 1.7× 464 1.8× 31 0.6× 24 0.5× 38 0.9× 15 581
Wiesław Kryczka Poland 12 483 1.8× 479 1.8× 106 2.1× 14 0.3× 51 1.2× 34 651
Hirotoshi Fujikawa Japan 9 220 0.8× 246 0.9× 22 0.4× 36 0.8× 26 0.6× 24 362
M. Gerotto Italy 16 554 2.1× 657 2.5× 102 2.0× 41 0.9× 49 1.2× 31 759
Leila Maria Moreira Beltrão Pereira Brazil 9 251 0.9× 237 0.9× 31 0.6× 11 0.2× 26 0.6× 19 385
Pascal Veillon France 13 407 1.5× 362 1.4× 50 1.0× 17 0.4× 34 0.8× 23 478
R. Stemerowicz Germany 8 349 1.3× 386 1.5× 40 0.8× 27 0.6× 20 0.5× 12 478

Countries citing papers authored by G Hess

Since Specialization
Citations

This map shows the geographic impact of G Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Hess more than expected).

Fields of papers citing papers by G Hess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Hess. The network helps show where G Hess may publish in the future.

Co-authorship network of co-authors of G Hess

This figure shows the co-authorship network connecting the top 25 collaborators of G Hess. A scholar is included among the top collaborators of G Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Hess. G Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rädle‐Hurst, Tanja, et al.. (2009). Growth differentiation factor (GDF) -15– a novel biomarker to assess the extent of liver fibrosis in patients with chronic liver disease?. Zeitschrift für Gastroenterologie. 47(1). 1 indexed citations
2.
Löhr, H, et al.. (2008). Monoklonale Gammopathie bei HIV-Infektion. DMW - Deutsche Medizinische Wochenschrift. 114(27). 1069–1072.
3.
Donck, J, Yves Vanrenterghem, A. Soumillion, et al.. (1998). Preferentially high prevalence of hepatitis G virus (HGV) infection as compared to HCV infection in patients undergoing chronic hemodialysis. Journal of Hepatology. 28. 119–119. 1 indexed citations
4.
Deutsch, Melanie, Spyridon P. Dourakis, E.K. Manesis, et al.. (1997). Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology. 26(1). 206–210. 136 indexed citations
5.
Hadziyannis, Stephanos J., et al.. (1993). Clinical significance of quantitative anti-HBc IgM assay in acute and chronic HBV infection.. PubMed. 40(6). 588–92. 12 indexed citations
6.
Janssen, Harry L.A., L Berk, Solko W. Schalm, et al.. (1992). Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.. Gut. 33(8). 1094–1098. 22 indexed citations
7.
Ramadori, Giuliano, Michael Manns, H. Rieder, et al.. (1991). Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. European Journal of Clinical Investigation. 21(3). 323–330. 54 indexed citations
8.
Hess, G, et al.. (1989). Epidemiologische, infektiologische und immunologische Ergebnisse aus der gynäkologischen HIV-Sprechstunde der UFK Mainz*. Geburtshilfe und Frauenheilkunde. 49(4). 385–389. 2 indexed citations
9.
10.
Hess, G, et al.. (1987). Relationship of pre‐S encoded antigens in liver and clinical manifestations of chronic hepatitis B infection. Liver International. 7(5). 245–250. 10 indexed citations
11.
Hess, G, et al.. (1987). Delta infection in Germany.. PubMed. 234. 433–4.
12.
Hess, G, W. Arnold, & K. H. Meyer zum Büschenfelde. (1981). Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine. Antimicrobial Agents and Chemotherapy. 19(1). 44–50. 16 indexed citations
13.
Hess, G, et al.. (1981). Transmission of hepatitis-B-virus by pleural effusion containing Dane particles.. PubMed. 28(3). 151–4. 2 indexed citations
14.
Manns, Michael P., K-H Meyer zum Büschenfelde, & G Hess. (1980). Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity. Gut. 21(11). 955–961. 56 indexed citations
15.
Hess, G, W. Arnold, B Möller, Gerhard M. Gahl, & K. H. Meyer zum Büschenfelde. (1980). Inhibition of hepatitis B virus specific DNA polymerase by intercalating agents. Medical Microbiology and Immunology. 168(1). 25–34. 4 indexed citations
16.
Arnold, Walter, et al.. (1979). [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].. PubMed. 17(10). 704–12. 6 indexed citations
17.
Hess, G, Walter Arnold, K. H. Meyer zum Büschenfelde, & R H Purcell. (1978). [Anti-HBc titer in HBeAg(e-antigen) and anti-HBe(anti-e) positive asymptomatic hepatitis B surface antigen (HBsAG) carriers].. PubMed. 943–5. 1 indexed citations
18.
Hess, G, J W Shih, Peter Kaplán, & John L. Gerin. (1977). The Demonstration of Subtype (D or Y)-Specific Determinants on the Surface of the Presumed Hepatitis B Virus. The Journal of Immunology. 119(4). 1542–1544. 12 indexed citations
19.
Arnold, Walter, G Hess, Meyer zum Büschenfelde Kh, et al.. (1976). [Simultaneous occurrence in the serum of hepatitis B surface antigen (HBsAg) and antibodies against HBsAg (Anti-HBs) of different subtypes. (Serologic and fluorescence histologic studies)].. PubMed. 82 Pt 1. 405–7. 6 indexed citations
20.
Knolle, J., et al.. (1976). Die Charakterisierung des klinisch gesunden Hepatitis-B-Antigen (HBsAg)-Trägers. Journal of Molecular Medicine. 54(12). 567–578. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Dal Pero Breakdown of academic impact, for papers by Juliane Halangk Breakdown of academic impact, for papers by Karl‐Herrmann Meyer zum Büschenfelde Breakdown of academic impact, for papers by Giuseppe Portera Breakdown of academic impact, for papers by Wiesław Kryczka Breakdown of academic impact, for papers by Hirotoshi Fujikawa Breakdown of academic impact, for papers by M. Gerotto Breakdown of academic impact, for papers by Leila Maria Moreira Beltrão Pereira Breakdown of academic impact, for papers by Pascal Veillon Breakdown of academic impact, for papers by R. Stemerowicz
Rankless by CCL
2026